Patients on semaglutide routinely notice reduced hunger, quicker fullness, diminished food cravings, enhanced energy for physical pursuits, and improved health metrics in blood pressure, cholesterol, and blood glucose
1060 Characterizing Variability in Patient Global Impression of Change (PGIC) and Severity (PGIS) Measures: Towards Standardization of PRO Design to Improve Development, Comparability, Translatability, and the Patient Experience Tim Poepsel 1 , Rebecca Israel 2 , Allyson Nolde 3 , Rachael Browning 4 , Chryso Hadjidemtriou 5 1 RWS, St
Phase Phase 2 Duration Weeks 5-8 Daily dose 7 mg Notes First therapeutic dose
Can I commit to regular physical activity